Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 24, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, news roundup

The past week has seen plenty of positive COVID-19 news; the Oxford-AstraZeneca vaccine was deemed safe and effective by the …

News

Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial

March 24, 2021
Research and Development COVID-19, Roche, covid-19 treatment

Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …

News
video_library01

Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan

March 22, 2021
Sales and Marketing COVID-19, Vaccine

Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

March 19, 2021
Medical Communications COVID, COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news

In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been …

News

RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine

March 19, 2021
Medical Communications COVID-19, Russia, Vaccine

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …

News

AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA

March 19, 2021
Medical Communications AstraZeneca, COVID-19, EMA, Vaccine

AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …

News

Florida woman gives birth to first-known baby born with COVID-19 antibodies

March 18, 2021
COVID-19, Moderna, Vaccine

A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …

News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 17, 2021
Research and Development COVID-19, covid-19 roundup, news roundup

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …

News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021
Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …

News
astrazeneca_sign_sky

Netherlands suspends AstraZeneca vaccine despite safety assurances

March 15, 2021
Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …

News
top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 12, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news

In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody …

News

Kintor’s COVID-19 treatment reduces mortality by 92%

March 12, 2021
Medical Communications Brazil, Brazil variant, COVID-19, Kintor, covid-19 treatment

Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial …

News

J&J’s one-shot COVID-19 vaccine approved by European Commission

March 12, 2021
Medical Communications COVID-19, EMA, Johnson & Johnson

The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced on Thursday. …

News

Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains

March 12, 2021
Medical Communications COVID-19, Novavax, vaccines

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …

News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021
Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025